AustinPx Gains FDA AMT Designation for KinetiSol Technology
GEORGETOWN, Texas — September 15, 2026 AustinPx announced that the U.S. Food and Drug Administration’s Center for Drug Evaluation...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
GEORGETOWN, Texas — September 15, 2026 AustinPx announced that the U.S. Food and Drug Administration’s Center for Drug Evaluation...
Reykjavik, Iceland, August 21, 2026 Alvotech, a biotechnology company focused on the development and manufacture of biosimilar medicines, has...
Rancho Cordova, California, USA, August 21, 2026 SK pharmteco, a global contract development and manufacturing organization (CDMO), has announced...
Cambridge, Massachusetts – August 4, 2026 Moderna, Inc. has announced the initiation of a Phase 1 clinical trial evaluating...
Redmond, Washington, August 5, 2026 SystImmune, Inc., a clinical-stage biotechnology company and subsidiary of Biokin, has announced that the...
Plano, Texas & New York – August 3, 2026 Integer Holdings Corporation, one of the world’s largest medical device...
